[PDF][PDF] Mecanismos de acción de RSUME sobre la función del supresor tumoral VHL y su impacto en el desarrollo del sindrome VHL asociados a la desregulación de …

L Tedesco - 2018 - bibliotecadigital.exactas.uba.ar
Los factores HIF son heterodímeros compuestos por dos subunidades, α y β. Mientras que
los niveles de HIF-β son constitutivos, la estabilidad y actividad de las subunidades HIF-1α y …

RSUME inhibits VHL and regulates its tumor suppressor function

J Gerez, L Tedesco, JJ Bonfiglio, M Fuertes… - Oncogene, 2015 - nature.com
Somatic mutations or loss of von Hippel–Lindau (pVHL) happen in the majority of VHL
disease tumors, which present a constitutively active Hypoxia Inducible Factor (HIF) …

The von Hippel–Lindau tumor suppressor, hypoxia-inducible factor-1 (HIF-1) degradation, and cancer pathogenesis

CW Pugh, PJ Ratcliffe - Seminars in cancer biology, 2003 - Elsevier
Recently, work on the mechanism of action of the von Hippel–Lindau tumour suppressor
protein (pVHL) and studies on hypoxic gene regulation have converged, providing insights …

Homotypic association between tumour-associated VHL proteins leads to the restoration of HIF pathway

J Chung, AM Roberts, J Chow, N Coady-Osberg… - Oncogene, 2006 - nature.com
Abstract The von Hippel-Lindau (VHL) tumour suppressor gene encodes a substrate-
specifying component of an E3 ubiquitin ligase that targets hypoxia-inducible factor (HIF) α …

The VHL tumor suppressor: master regulator of HIF

VH Haase - Current pharmaceutical design, 2009 - ingentaconnect.com
Hypoxia-inducible factors (HIFs) are heterodimeric oxygen-sensitive basic helix-loop-helix
transcription factors that play central roles in cellular adaptation to low oxygen environments …

Role of the C-terminal α-helical domain of the von Hippel–Lindau protein in its E3 ubiquitin ligase activity

MD Lewis, BJ Roberts - Oncogene, 2004 - nature.com
In the present study, the role of the C-terminal α-helical domain (amino acid (aa) 195–208)
of the von Hippel–Lindau (VHL) tumour suppressor was investigated. Deletions of the VHL …

Subcellular dynamics of the VHL tumor suppressor: on the move for HIF degradation

M Khacho, S Lee - 2009 - Taylor & Francis
The von Hippel–Lindau (VHL) tumor suppressor protein, the recognition component of an
E3 ubiquitin ligase complex, recruits the α-subunit of the hypoxia-inducible factor (HIFα) for …

VHL Gene Mutations and Their Effects on Hypoxia Inducible Factor HIFα: Identification of Potential Driver and Passenger Mutations

MP Rechsteiner, A von Teichman, A Nowicka, T Sulser… - Cancer research, 2011 - AACR
Mutations of the von Hippel-Lindau (VHL) gene are frequent in clear cell renal cell
carcinomas (ccRCC). Nonsense and frameshift mutations abrogate the function of the VHL …

Role of the von Hippel-Lindau tumour suppressor protein in the regulation of HIF-1α and its oxygen-regulated transactivation domains at high cell density

SM Paltoglou, BJ Roberts - Oncogene, 2005 - nature.com
Abstract Hypoxia-inducible factor-1α (HIF-1α) induction and associated transcription were
investigated during high cell density, focusing on the negative regulator of HIF-1α …

[HTML][HTML] Ubiquitin pathway in VHL cancer syndrome

M Ohh - Neoplasia, 2006 - Elsevier
The physiologic response to changes in cellular oxygen tension is ultimately governed by a
heterodimeric transcription factor called hypoxia-inducible factor (HIF), which, in adaptation …